Screenshots

Description

The aim of the MIPOGG decision-support tool is to help healthcare professionals identify which of their patients with cancer have a higher likelihood of having an underlying cancer predisposition syndrome. This tool provides genetic referral guidelines for patients, aged 0-18 years, who are/have been diagnosed with cancer. The MIPOGG decision-support tool is not designed to replace a clinician’s judgment. A physician’s clinical judgment that a referral may or may not be appropriate should override the MIPOGG recommendations. The MIPOGG does not substitute the need for formal genetic counselling and assessment prior to genetic testing. This screening tool cannot reliably identify 100% of children with a cancer predisposition syndrome. It may suggest referrals for patients who are subsequently deemed not to have a cancer predisposition syndrome, or for patients in whom a cancer predisposition syndrome is not yet identified based on current knowledge. Alternatively, the MIPOGG may suggest that a referral is not needed. It is possible, in this scenario, that a patient may subsequently be diagnosed with a cancer predisposition syndrome with the advent of new research and knowledge, or with evolution in the patient’s clinical status. The MIPOGG recommendations are based on current scientific knowledge and will be updated at regular intervals, as relevant new scientific information becomes available. The date of the last update is published on the MIPOGG website and its associated application. The referenced articles are suggested readings, and do not constitute a complete list of all the relevant literature used to compile the guidelines. All rights reserved. No part of this publication may be reproduced or transmitted in any form or by any means without the prior written permission of the copyright holder.

What’s New

Version 2.0.0

Added sounds and dynamic pages. Fixed bugs that were occurring when browsing some tumors.

Ratings and Reviews

5.0 out of 5
4 Ratings

4 Ratings

Claudibidi ,

Innovative and effective

This app is innovative and effective. It helps provide answers regarding cancer predisposition syndromes. The clinician and genetic teams have done a wonderful job at making this tool both easy to use and informative. A must have for any health professional that works with cancer patients!

ClioMb ,

Regularly use this app

I am a clinical research nurse working in the hematology/ oncology department and I routinely use this application for my patients. (I in fact use it for all new diagnosis)
It is very simple to use. The information is clear- concise and informative.
I will continue to use this app to aide my practice.

larzipan59 ,

Game changer

MIPOGG is a quick and efficient way to better understand which people diagnosed with a childhood cancer could be evaluated in genetics. It simplifies the process by asking yes/no questions that can be completed in a couple of minutes. MIPOGG rationalizes the process of referring and provides educational modules to help better understand which cancer predisposition syndromes someone may be at risk for.

App Privacy

The developer, CG-MED Inc., has not provided details about its privacy practices and handling of data to Apple. For more information, see the developer's privacy policy.

No Details Provided

The developer will be required to provide privacy details when they submit their next app update.

Supports

  • Family Sharing

    Up to six family members will be able to use this app with Family Sharing enabled.

You Might Also Like